SARS-CoV-2 N protein induces alveolar epithelial apoptosis via NLRP3 pathway in ARDS
- PMID: 39591821
- DOI: 10.1016/j.intimp.2024.113503
SARS-CoV-2 N protein induces alveolar epithelial apoptosis via NLRP3 pathway in ARDS
Abstract
Acute Respiratory Distress Syndrome (ARDS) is a severe inflammatory condition often resulting from sepsis and viral infections, including (Severe Acute Respiratory Syndrome Coronavirus 2) SARS-CoV-2. This study investigates the molecular mechanisms by which the SARS-CoV-2 nucleocapsid (N) protein influences alveolar macrophage activation, leading to alveolar epithelial cell apoptosis and exacerbating ARDS. Single-cell RNA sequencing data from ARDS patients were analyzed to identify cell subpopulations and their interactions, revealing significant macrophage-epithelial cell communication through the (NOD-like receptor family pyrin domain containing 3) NLRP3 pathway. Differential gene expression in SARS-CoV-2-infected macrophages highlighted key genes, with WGCNA pinpointing core modules. In vitro experiments demonstrated that N protein overexpression in MH-S macrophages activates the NLRP3 pathway, promoting M1 macrophage polarization and inducing apoptosis in co-cultured MLE-12 epithelial cells. Immunoprecipitation, pull-down assays, Enzyme-Linked Immunosorbent Assay (ELISA), RT-qPCR, Western blotting, and flow cytometry confirmed these findings. In vivo, ARDS mouse models induced by CLP surgery or N protein administration showed increased M1 macrophage infiltration, heightened inflammatory responses, and significant epithelial cell damage, as evidenced by H&E staining, immunofluorescence, RNA-ISH, and ELISA. These results suggest that the SARS-CoV-2 N protein activates the NLRP3 signaling pathway, driving M1 macrophage polarization and the release of pro-inflammatory factors, thereby inducing alveolar epithelial cell apoptosis and worsening ARDS. Targeting this pathway may provide new therapeutic avenues for treating ARDS associated with SARS-CoV-2.
Keywords: Acute Respiratory Distress Syndrome (ARDS); Alveolar macrophages; Epithelial cell apoptosis; Inflammatory response; NLRP3 signaling pathway; SARS-CoV-2N protein.
Copyright © 2024 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
ATG16L1 restrains macrophage NLRP3 activation and alveolar epithelial cell injury during septic lung injury.Clin Transl Med. 2025 Apr;15(4):e70289. doi: 10.1002/ctm2.70289. Clin Transl Med. 2025. PMID: 40211890 Free PMC article.
-
Cirsium japonicum leaf extract attenuated lipopolysaccharide-induced acute respiratory distress syndrome in mice via suppression of the NLRP3 and HIF1α pathways.Phytomedicine. 2025 May;140:156601. doi: 10.1016/j.phymed.2025.156601. Epub 2025 Mar 2. Phytomedicine. 2025. PMID: 40064116
-
Geranylgeranyl diphosphate synthase 1 knockdown suppresses NLRP3 inflammasome activity via promoting autophagy in sepsis-induced acute lung injury.Int Immunopharmacol. 2021 Nov;100:108106. doi: 10.1016/j.intimp.2021.108106. Epub 2021 Sep 13. Int Immunopharmacol. 2021. PMID: 34530204
-
The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach.Life Sci. 2020 Oct 1;258:118166. doi: 10.1016/j.lfs.2020.118166. Epub 2020 Jul 31. Life Sci. 2020. PMID: 32739471 Free PMC article. Review.
-
Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics.Protein Cell. 2020 Oct;11(10):707-722. doi: 10.1007/s13238-020-00738-2. Epub 2020 Jun 9. Protein Cell. 2020. PMID: 32519302 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous